Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter.
about
Molecular cloning, tissue distribution and androgen regulation of rat protein C inhibitorAn interactive mutation database for human coagulation factor IX provides novel insights into the phenotypes and genetics of hemophilia B.Localization of hepatocyte nuclear factor-4α in the nucleolus and nucleus is regulated by its C-terminusHaemophilia A and haemophilia B: molecular insightsCell- and gene-specific regulation of primary target genes by the androgen receptor.Factor IX and thrombosis.A CpG mutational hotspot in a ONECUT binding site accounts for the prevalent variant of hemophilia B Leyden.Genetic sequence analysis of inherited bleeding diseases.Regulatory mutations and human genetic disease.Multi-species, multi-transcription factor binding highlights conserved control of tissue-specific biological pathways.Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis.A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia.Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodemaClinical utility gene card for: haemophilia B.The endothelial-specific regulatory mutation, Mvwf1, is a common mouse founder allele.Binding of the Ets factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transactivationTranscriptional regulation of the gene coding for human protein C.An age-related homeostasis mechanism is essential for spontaneous amelioration of hemophilia B LeydenOrphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter.Recent advances in hemophilia B therapy.The activation function 2 domain of hepatic nuclear factor 4 is regulated by a short C-terminal proline-rich repressor domain.The HNF1/HNF4-dependent We2 element of woodchuck hepatitis virus controls viral replication and can activate the N-myc2 promoter.Regulatory gene mutations affecting apolipoprotein gene expression: functions and regulatory behavior of known genes may guide future pharmacogenomic approaches to therapy.A mutant androgen receptor from patients with Reifenstein syndrome: identification of the function of a conserved alanine residue in the D box of steroid receptors.Gene therapy expression vectors based on the clotting Factor IX promoter.Role of intron I in expression of the human factor IX gene.Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4 alpha.The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene.Haemophilia B Brandenberg-type promoter mutation.First case report of hemophilia B Leyden in Japan.The high frequency of the -6G-->A factor IX promoter mutation is the result both of a founder effect and recurrent mutation at a CpG dinucleotide.Effect of age on factor IX levels in symptomatic carriers of Haemophila B Leyden.Haemophilia B Liverpool: a new British family with mild haemophilia B associated with a -6 G to A mutation in the factor IX promoter.A case of non-resolving hemophilia B Leyden in a 42-year-old male (F9 promoter + 13 A>G).Androgen effects on factor IX expression: in-vitro and in-vivo studies in mice.cis-acting elements and transcription factors involved in the promoter activity of the human factor VIII gene.Cloning and characterization of the human factor XI gene promoter: transcription factor hepatocyte nuclear factor 4alpha (HNF-4alpha ) is required for hepatocyte-specific expression of factor XI.The tree squirrel HP-25 gene is a pseudogene.Haemophilia A and haemophilia B: molecular insights.
P2860
Q28574102-C969E85F-28D0-4D4A-AB2D-B64551DED4BFQ30429771-7413AFD3-27E0-4416-A069-63CE219A3384Q33603307-590EFCDA-3D5B-4225-8461-5DCBB470E2ACQ33918888-D7D485D9-FA3D-4038-B559-0E80E10A61DCQ34005736-064355A5-C24B-41B3-8E95-B03A7E072B0DQ34104373-E8B52697-1BE7-404B-A8CA-D789DE768DB6Q34331863-E8FDFF29-8421-4A8B-BD88-92F5BA2FBD80Q34663589-92EA8944-4626-41A6-A990-B2D017E11816Q35164314-197947C6-9338-4168-A15E-917ACC6ED566Q35176534-0CD1F00B-FEF9-4982-9917-B87B3949A20DQ35809927-98FC34BB-CF03-4249-9AAE-5C4B0FA4259CQ35860457-C570B718-F27C-4CB2-B674-1BCA42B3AAC1Q35881940-5F875331-A404-4019-B59A-0FEA1656FB6DQ35899385-31D8B7E8-81E1-48F7-8C26-2A6CB9A3159CQ36428412-B3E572EA-CE4D-4992-B901-175D429DCA5BQ36558883-817C59EE-1A28-4BBC-A551-DD74EEE6EA81Q36798033-E738C3F2-596C-45B9-9D12-CFA224D28712Q37172394-2F64C569-E18C-4AB2-A2B6-A62B672C28A5Q38291133-72A8D78E-9F6E-4BAB-B483-2EF4B4E4B6C5Q39154043-E89390DE-9DFB-415D-AC36-4076AF9918F5Q39723698-1F7ED47B-5822-4503-A1BE-B14ABAB18D6AQ39877239-4332A4FA-5C09-414E-B54B-D3B23A0884A6Q40588297-B56A1358-340B-49E7-A145-480426E49C8EQ40657153-858947A5-8989-4543-9CBC-507B31D4648DQ40928425-78648E41-9C67-4AFE-B686-AACB0360540EQ41360681-A76A7139-82C8-4C9B-A2EE-1735F4D91613Q45729090-51735302-111C-4585-BC4E-CB036EA6FDBCQ45750343-4754D9B2-0CD1-4B07-8CF0-5D7F04F1B601Q45857763-55E4D4BE-B03F-4DDF-9159-6BC4139BE9E8Q45864402-B0D4D0FB-7FFF-4B5C-8D8D-7CF12D586B9BQ45868984-4ED8D27F-21D7-4D2A-AE88-F37E444639B2Q45870028-236B0508-20B3-4478-A054-193001CA3290Q45873503-81D69F24-D2AB-4113-A484-A8FEF8BB5DDFQ45875677-F8F00A1C-4EFA-4FD2-8905-8F436ACDE448Q45887434-2600D05C-AD36-4868-BB0F-A76A0CCD1BABQ48073646-2E2E9A6C-0790-4DF1-8A4F-D93DAA0CB543Q48313850-D3A38584-3CA6-4A31-8A94-E6FBC3C0D9A4Q48331426-E4F479C1-CED2-44EB-867E-88D2BD55C418Q53315892-8F890A22-1F23-4383-AF89-6237F9DD12EA
P2860
Recovery from hemophilia B Leyden: an androgen-responsive element in the factor IX promoter.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Recovery from hemophilia B Ley ...... ent in the factor IX promoter.
@ast
Recovery from hemophilia B Ley ...... ent in the factor IX promoter.
@en
Recovery from hemophilia B Ley ...... ent in the factor IX promoter.
@nl
type
label
Recovery from hemophilia B Ley ...... ent in the factor IX promoter.
@ast
Recovery from hemophilia B Ley ...... ent in the factor IX promoter.
@en
Recovery from hemophilia B Ley ...... ent in the factor IX promoter.
@nl
prefLabel
Recovery from hemophilia B Ley ...... ent in the factor IX promoter.
@ast
Recovery from hemophilia B Ley ...... ent in the factor IX promoter.
@en
Recovery from hemophilia B Ley ...... ent in the factor IX promoter.
@nl
P2093
P921
P356
P1433
P1476
Recovery from hemophilia B Ley ...... ent in the factor IX promoter.
@en
P2093
P304
P356
10.1126/SCIENCE.1631558
P407
P577
1992-07-01T00:00:00Z